• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

J&J looks to ex­pand Trem­fya in two pe­di­atric in­di­ca­tions

5 months ago
Pharma
FDA+

Scott Got­tlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this coun­try’

5 months ago
People
FDA+

Bio­con lands FDA ap­proval for an­oth­er Ste­lara biosim­i­lar

5 months ago
Pharma
FDA+

Ole­ma, No­var­tis ink an­oth­er agree­ment, this time for a late-stage breast can­cer tri­al

5 months ago
Deals
R&D

Novo­cure says elec­tric field ther­a­py ex­tends life for pan­cre­at­ic can­cer pa­tients by two months

5 months ago
R&D

Sen­ti Bio’s Phase 1 CAR-NK da­ta; Allink rais­es $42M

5 months ago
News Briefing

Agenus launch­es bi­o­log­ics man­u­fac­tur­ing busi­ness to gen­er­ate cash

5 months ago
Financing
Manufacturing

No­var­tis pays $1B up­front for PTC's Phase 2 Hunt­ing­ton's drug

5 months ago
Deals
Pharma

Merus drug shows ‘un­ex­pect­ed im­prove­ment’ in sec­ond-line head and neck can­cer study

5 months ago
R&D

Apogee tar­gets Dupix­ent head-to-head next year as it out­lines broad pipeline plans

5 months ago
R&D

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

5 months ago
R&D
FDA+

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take blue­bird's Skysona gene ther­a­py

5 months ago
Pharma
Cell/Gene Tx

Sat­suma's NDA fil­ing af­ter CMC woes; Hov­ione's Irish and US ex­pan­sion

5 months ago
Manufacturing

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

5 months ago
People
Pharma

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

5 months ago
Pharma

Out­look's shares crash as wet AMD drug flunks Phase 3 test

5 months ago
R&D

Re­cur­sion re­duces work­force; Ox­ford Nanopore teams up with UK Biobank

5 months ago
News Briefing

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

5 months ago
Pharma
Law

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

5 months ago
People

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

5 months ago
R&D
FDA+

Aca­dia snaps up an es­sen­tial tremor drug af­ter field­'s sum­mer set­backs

5 months ago
Startups
Deals

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

5 months ago
People
Deals

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

5 months ago
People
FDA+

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

5 months ago
Pharma
FDA+
First page Previous page 59606162636465 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.